Prosensa Holding BV (RNA)

[oldberkeley]

I think the news is huge but not sure what the sci community thinks

Some are a bit sceptical of the subset analysis that is the basis for today's news, and realize that GSK saw the same data and gave drisapersen back to Prosensa.

So it's far from a slam dunk, but just the news that all is not lost, that further testing and FDA submissions will occur, should be enough to drive the PPS back to more normal and realistic evaluations.

Short-term traders selling today, and good for them. But I'm looking for at least $10 in the next month if not sooner.

Best of luck.